Paper22018607
Transplantation of oligodendrocyte precursor cells improves myelination and promotes functional recovery after spinal cord injury.
Wu B and 5 others. Injury, 2012. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Transplantation of oligodendrocyte precursor cells improves myelination and promotes functional recovery after spinal cord injury. Papers, record 22018607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22018607
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Transplantation of oligodendrocyte precursor cells improves myelination and promotes functional recovery after spinal cord injury.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Demyelinating Diseases | Major topic |
| Myelin Sheath | Major topic |
| Oligodendroglia | Major topic |
| Spinal Cord Injuries | Major topic |
| Stem Cell Transplantation | Major topic |
| Animals | |
| Cell Differentiation | |
| Cells, Cultured | |
| Disease Models, Animal | |
| Female | |
| Immunohistochemistry | |
| Neural Conduction | |
| Rats | |
| Rats, Sprague-Dawley | |
| Recovery of Function |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769555 | Myelin Impairment and Regeneration in the Central Nervous System: Molecular Mechanisms, Diseases, and Prospective Therapeutic Targets. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42769555 | PubMed |
| 41595651 | Glial Cell Dynamics in Neuroinflammation: Mechanisms, Interactions, and Therapeutic Implications. | Biomedicines | 2026 | https://conductscience.org/library/papers/41595651 | PubMed |
| 41594626 | The Scent of a Therapy for Spinal Cord Injury: Growth Factors and Their Potential to Modulate Olfactory Ensheathing Cells. | Biomolecules | 2026 | https://conductscience.org/library/papers/41594626 | PubMed |
| 40806380 | Spinal Cord Injury Remyelination: Pathways to Therapies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806380 | PubMed |
| 40500499 | Plasticity of Myelination. | Adv Neurobiol | 2025 | https://conductscience.org/library/papers/40500499 | PubMed |
| 39872018 | Cryopreservation of primary neonatal rat oligodendrocytes and recapitulation of in vitro oligodendrocyte characteristics. | Front Cell Neurosci | 2024 | https://conductscience.org/library/papers/39872018 | PubMed |
| 38655345 | A primary culture method for the easy, efficient, and effective acquisition of oligodendrocyte lineage cells from neonatal rodent brains. | Heliyon | 2024 | https://conductscience.org/library/papers/38655345 | PubMed |
| 37239968 | Impact of Endurance Training on Regeneration of Axons, Glial Cells, and Inhibitory Neurons after Spinal Cord Injury: A Link between Functional Outcome and Regeneration Potential within the Lesion Site and in Adjacent Spinal Cord Tissue. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37239968 | PubMed |
| 36759606 | Segmental motor recovery after cervical spinal cord injury relates to density and integrity of corticospinal tract projections. | Nat Commun | 2023 | https://conductscience.org/library/papers/36759606 | PubMed |
| 36619671 | Neurogenesis potential of oligodendrocyte precursor cells from oligospheres and injured spinal cord. | Front Cell Neurosci | 2022 | https://conductscience.org/library/papers/36619671 | PubMed |
| 35723326 | Mesenchymal Stem Cells in the Treatment of Human Spinal Cord Injury: The Effect on Individual Values of pNF-H, GFAP, S100 Proteins and Selected Growth Factors, Cytokines and Chemokines. | Curr Issues Mol Biol | 2022 | https://conductscience.org/library/papers/35723326 | PubMed |
| 31732865 | Epidural Spinal Cord Stimulation Promotes Motor Functional Recovery by Enhancing Oligodendrocyte Survival and Differentiation and by Protecting Myelin after Spinal Cord Injury in Rats. | Neurosci Bull | 2020 | https://conductscience.org/library/papers/31732865 | PubMed |
| 31419426 | Brief review: Can modulating DNA methylation state help the clinical application of oligodendrocyte precursor cells as a source of stem cell therapy? | Brain Res | 2019 | https://conductscience.org/library/papers/31419426 | PubMed |
| 31231194 | Generation of Oligodendrocyte Progenitor Cells From Mouse Bone Marrow Cells. | Front Cell Neurosci | 2019 | https://conductscience.org/library/papers/31231194 | PubMed |
| 30221695 | CXCL12 induces migration of oligodendrocyte precursor cells through the CXCR4‑activated MEK/ERK and PI3K/AKT pathways. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/30221695 | PubMed |
| 28469664 | The mechanism of Naringin-enhanced remyelination after spinal cord injury. | Neural Regen Res | 2017 | https://conductscience.org/library/papers/28469664 | PubMed |
| 27879672 | Electric Signals Regulate the Directional Migration of Oligodendrocyte Progenitor Cells (OPCs) via β1 Integrin. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27879672 | PubMed |
| 27085393 | Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials? | Exp Neurol | 2016 | https://conductscience.org/library/papers/27085393 | PubMed |
| 26384702 | Combination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury. | Acta Biomater | 2015 | https://conductscience.org/library/papers/26384702 | PubMed |
| 24242317 | Promoting remyelination in multiple sclerosis-recent advances. | Drugs | 2013 | https://conductscience.org/library/papers/24242317 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22018607
GET https://conductscience.org/api/papers/v1/22018607/cited_by?page=2